US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

10.15

+0.13001.30%

Post-market: 10.150.00000.00%16:25 EDT

Volume:2.62M

Turnover:26.61M

Market Cap:7.24B

PE:-65.20

High:10.22

Open:10.05

Low:10.01

Close:10.02

Loading ...

Overview Company News Filings

BRIEF-Roivant Sciences Q3 EPS USD 0.23

Roivant Sciences Q3 Net Income USD 118.075 Million

THOMSON REUTERS

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

THOMSON REUTERS

Press Release: Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

Calendar of U.S. Earnings Expected in the Week Ahead

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025

THOMSON REUTERS

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025

Bank of America Securities Reaffirms Their Hold Rating on Roivant Sciences (ROIV)

Roivant Sciences Ltd : Guggenheim Cuts Target Price to $15 From $16

THOMSON REUTERS

Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing

Roivant Sciences (ROIV) Receives a Buy from Leerink Partners

How Elon Musk and Vivek Ramaswamy teamed up to gut $2 trillion of government spending

Roivant Sciences Shares Down 3% as Co to Stop Lung Disease Drug Development After Trial Failure

THOMSON REUTERS

Roivant Sciences' Kinevant Says Pulmonary Sarcoidosis Drug Candidate Fails to Meet Goals

MT Newswires Live

Roivant Sciences Unit Kinevant Sciences' Lung Disease Drug Fails in Mid-Stage Study

BUZZ-Roivant falls as lung disease drug fails in mid-stage study

Roivant's lung disease drug fails mid-stage trial

Roivant Sciences Shares Down 2.6% Premarket After Co's Lung Disease Drug Fails to Meet Main Goal in Mid-Stage Study

THOMSON REUTERS

Kinevant Sciences Announces Topline Results From Phase 2 Resolve-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

THOMSON REUTERS

Roivant Announces Topline Results From Phase 2 Resolve-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ROIV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":10.15,"timestamp":1744920000000,"preClose":10.02,"halted":0,"volume":2621846,"hourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.15,"latestTime":"16:25 EDT","volume":86182,"amount":874745.86,"timestamp":1744921542063},"delay":0,"floatShares":370552084,"shares":713549458,"eps":-0.155667,"marketStatus":"Closed Good Friday","change":0.13,"latestTime":"04-17 16:00:00 EDT","open":10.05,"high":10.219,"low":10.01,"amount":26606364.639989,"amplitude":0.020858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.155667,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":10.02,"preHourTrading":{"tag":"盘前","latestPrice":10.08,"preClose":10.02,"latestTime":"09:29 EDT","volume":1674,"amount":16873.920000000002,"timestamp":1744896599999},"postHourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.15,"latestTime":"16:25 EDT","volume":86182,"amount":874745.86,"timestamp":1744921542063},"volumeRatio":0.3971480489691445,"impliedVol":0.3401,"impliedVolPercentile":0.6813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":370552084,"roa":"-11.62%","roe":"-14.64%","lyrEps":5.552418,"volumeRatio":0.3971480489691445,"shares":713549458,"dividePrice":0,"high":10.219,"amplitude":0.020858,"preClose":10.02,"low":10.01,"week52Low":8.73,"pbRate":"1.40","psRate":"59.08","week52High":13.055,"institutionHeld":0,"latestPrice":10.15,"eps":-0.155667,"divideRate":0,"volume":2621846,"delay":0,"ttmEps":-0.155667,"open":10.05,"prevYearClose":11.83,"prevWeekClose":9.86,"prevMonthClose":10.09,"prevQuarterClose":10.09,"fiveDayClose":9.65,"twentyDayClose":10.97,"sixtyDayClose":11.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510551748","title":"BRIEF-Roivant Sciences Q3 EPS USD 0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2510551748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510551748?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188846,"startTime":"0","endTime":"0","summary":"BRIEF-Roivant Sciences Q3 EPS USD 0.23\n\n\nFeb 10 (Reuters) - Roivant Sciences Q3 operating expenses USD 283.399 million.\n\nQ3 income from operations USD -274.381 million vs. IBES estimate USD -275.2 million\nQ3 net income USD 118.075 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nPLX5E5349:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"gpt_icon":0},{"id":"2510685515","title":"Roivant Sciences Q3 Net Income USD 118.075 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2510685515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510685515?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nPLX5E5349:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2510855151","title":"Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510855151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510855151?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA3CDS3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2510855127","title":"Press Release: Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510855127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510855127?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188800,"startTime":"0","endTime":"0","summary":"Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update. BASEL, Switzerland and LONDON and NEW YORK, Feb. 10, 2025  -- Roivant  today reported its financial results for the third quarter ended December 31, 2024, and provided a business update.-- Brepocitinib to be developed in third indication, cutaneous sarcoidosis. , an orphan indication with high unmet need; Phase 2 study initiation. expected in second quarter of calendar year with topline data in second. -- Roivant reported consolidated cash, cash equivalents, restricted cash and. marketable securities of approximately $5.2 billion at December 31, 2024,investor, a large mutual fund complex, and Roivant, bringing Roivant's. deep IgG reduction in the treatment of GD for patients who are n","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","LU0170899867.USD","BK4588","BK4123","ROIV","BK4139","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4007","BK4550","BK4187","BK4516","GD","MG","BK4585","BK4566","IE0031619046.USD"],"gpt_icon":0},{"id":"2509719826","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2509719826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509719826?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:00","pubTimestamp":1738926000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·A-Mark Precs Mtls                               2Q       .64    4:05 PM. ·Byrna Tech Inc.                                 4Q       .11    8:00 AM. ·Flowers Foods Inc.                               4Q       .20    7:00 AM. ·GrafTech Intl Ltd.                               4Q      (.12)   6:40 AM. ·Green Plains Inc.                               4Q      (.35)   6:55 AM. ·Plains All Amer Ppln                             4Q       .41    7:30 AM. ·Plains GP Hldgs                                 4Q       .46    7:30 AM. ·Proto Labs Inc.                                 4Q       .32    6:00 AM. ·Apollo Comm Rl Est                               4Q       .24        AMC. ·Bank of N.T. Buttrfld                            4Q      1.15    4:30 PM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KIM","BBD","MYTE","ROAD","LYFT","MAR","BL","ADC","CG","CGC","BAP","FRSH","AVTR","BIOX","ECG","GCMG","MEDP","PFLT","HIW","BSAC","ROIV","AIZ","HIVE","FLO","KO","GNSS","MAS","ALSN","PRLB","NWL","FLNC","CRNT","CNA","CARR","DASH","INSP","GLAD","XAIR","ARWR","FIS","MRC","GHM","GILD","ARI","ON","AKR","WTS","ULCC","ANGI"],"gpt_icon":1},{"id":"2507431663","title":"Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507431663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507431663?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUA2HRBLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2507450665","title":"Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507450665","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507450665?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184700,"startTime":"0","endTime":"0","summary":"BASEL, Switzerland and LONDON and NEW YORK, Jan. 29, 2025  -- Roivant  today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, February 10, 2025, to report its financial results for the third quarter ended December 31, 2024, and provide a business update.Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our product candidates, the availability and s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/roivant-report-financial-results-third-210500003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"2503525023","title":"Bank of America Securities Reaffirms Their Hold Rating on Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503525023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503525023?lang=en_us&edition=fundamental","pubTime":"2025-01-14 19:30","pubTimestamp":1736854253,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Chi Meng Fong maintained a Hold rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-hold-rating-on-roivant-sciences-roiv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-hold-rating-on-roivant-sciences-roiv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAC","ROIV"],"gpt_icon":0},{"id":"2500191605","title":"Roivant Sciences Ltd : Guggenheim Cuts Target Price to $15 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2500191605","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500191605?lang=en_us&edition=fundamental","pubTime":"2025-01-03 19:28","pubTimestamp":1735903734,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250103:nFWN3NZ0B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2500194586","title":"Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2500194586","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500194586?lang=en_us&edition=fundamental","pubTime":"2025-01-02 16:28","pubTimestamp":1735806533,"startTime":"0","endTime":"0","summary":"A lackluster trading persisted throughout the last day of the year, with Wall Street’s main indices ending the day mixed.The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent. Meanwhile, NYSE Composite inched up by 0.10 percent and S&P Composite rose by 0.44 percent.Shares of Roivant Sciences  rallied on Wednesday, ending the day up by 3.5 percent at $11.83 each. Year-to-date, the company’s stock price grew by 4.22 percent from the $11.35 registered on January 2, 2024.While there were no clear catalysts that could perk up its share prices, investors seemed to have snapped up its shares while waiting on the sidelines for the Trump administration’s return to office. Roivant’s  co-founder, Vivek Ramaswamy is set to join the incoming administration in a high-profile role, serving as the co-head of the Department of Government Efficiency , along with technology mogul Elon Musk.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-roivant-sciences-ltd-roiv-082153766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4079","ROIV","NQmain","QID","PSQ",".IXIC","COMP","SQQQ","TQQQ","MNQmain","USAW.SI","BK4539","USJW.SI","TSYW.SI","BK4007","QLD","BK4139","NVIW.SI"],"gpt_icon":1},{"id":"2492249479","title":"Roivant Sciences (ROIV) Receives a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2492249479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492249479?lang=en_us&edition=fundamental","pubTime":"2024-12-18 13:36","pubTimestamp":1734500213,"startTime":"0","endTime":"0","summary":"In a report released on December 15, David Risinger from Leerink Partners reiterated a Buy rating on Roivant Sciences (ROIV – Research Report). The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-leerink-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-leerink-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2491693731","title":"How Elon Musk and Vivek Ramaswamy teamed up to gut $2 trillion of government spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693731","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693731?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:06","pubTimestamp":1734354360,"startTime":"0","endTime":"0","summary":"DOGE will have to go after Social Security and health programs to hit its targets. Some in Washington don't believe it stands a chance.A little over a year ago, Elon Musk and Vivek Ramaswamy didn't know each other. Then the two hopped on X Spaces along with venture capitalist David Sacks. \"I would like to know more about you,\" Musk told Ramaswamy, who was running for the Republican presidential nomination at the time.Now, Musk and Ramaswamy have teamed up to cut $2 trillion in annual government spending, or more than 30% of the federal budget, within two years.They've been tasked by President-elect Donald Trump to run a department focused on \"government efficiency,\" called DOGE.  The advisory body, which will not be an official department of the federal government, promises to radically shake up the federal bureaucracy and massively cut federal spending in the process.The Clinton effort to cut spending and modernize government services saved $112 billion over eight years, and led to si","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0056508442.USD","LU0820562030.AUD","LU2602419157.SGD","IE00BWXC8680.SGD","LU2326559502.SGD","SG9999015952.SGD","LU2357305700.SGD","LU1145028129.USD","LU2249611893.SGD","LU0820561909.HKD","LU1861559042.SGD","IE00BSNM7G36.USD","SG9999015978.USD","LU0082616367.USD","IE00BK4W5L77.USD","LU1429558221.USD","LU1839511570.USD","LU1914381329.SGD","IE00BK4W5M84.HKD","LU1629891620.HKD","BK4581","ROIV","LU0466842654.USD","LU0964807845.USD","BK4516","LU2063271972.USD","LU0198837287.USD","LU0053666078.USD","LU0234570918.USD","IE00BJLML261.HKD","LU0820561818.USD","LU2360106780.USD","LU1720051017.SGD","LU1548497426.USD","LU1435385759.SGD","BK4007","LU0823414478.USD","TSLA","BK4534","LU0943347566.SGD","LU1861220033.SGD","BK4592","SG9999015986.USD","IE00B1XK9C88.USD","BK4550","TSYW.SI","LU0719512351.SGD","LU1551013342.USD","BK4555"],"gpt_icon":1},{"id":"2488694636","title":"Roivant Sciences Shares Down 3% as Co to Stop Lung Disease Drug Development After Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2488694636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488694636?lang=en_us&edition=fundamental","pubTime":"2024-12-03 22:46","pubTimestamp":1733237189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N40IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2488914939","title":"Roivant Sciences' Kinevant Says Pulmonary Sarcoidosis Drug Candidate Fails to Meet Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914939","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914939?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:59","pubTimestamp":1733230763,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) said Tuesday its  Kinevant Sciences unit's phase 2 Resolve-Lung trial for namilumab in chronic active pulmonary sarcoidosis failed to meet its primary and secondary endpoints.N","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"2488118869","title":"Roivant Sciences Unit Kinevant Sciences' Lung Disease Drug Fails in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488118869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488118869?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:35","pubTimestamp":1733229300,"startTime":"0","endTime":"0","summary":"Roivant Sciences said its subsidiary Kinevant Sciences' phase 2 study of Namilumab failed to show treatment benefit in patients with chronic active pulmonary sarcoidosis.The phase 2 study showed that Namilumab failed to meet the primary endpoint of proportion of subjects with a rescue event during the double-blind period. Rescue event was defined as clinically significant worsening of a subject's disease requiring treatment, failure to adhere to protocol, or premature discontinuation from the study associated with lack of benefit during the double-blind treatment period.Pulmonary sarcoidosis is a lung disease characterized by the presence of clumps of immune cells that can cause breathlessness, fatigue and pain.The study's secondary goals, including change in percent predicted forced vital capacity, corticosteroid tapering success, and change in the patient reported King's Sarcoidosis Questionnaire failed to show a treatment benefit consistent with the primary endpoint.The safety profi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI","BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"2488199889","title":"BUZZ-Roivant falls as lung disease drug fails in mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488199889","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488199889?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:28","pubTimestamp":1733228928,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant falls as lung disease drug fails in mid-stage study ** Shares of Roivant Sciences ROIV.O fall 2.2% to $12.20 before the bell** Co says its experimental lung disease drug, namilumab, did not meet the main and secondary goals in a mid-stage study** Co was testing namilumab in patients with chronic active pulmonary sarcoidosis, a condition in which lumps of inflammatory cells form in the lungs** Adds that it will stop further development of the drug to treat sarcoidosis** As of last close, ROIV up 11% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3N3N40UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2488191653","title":"Roivant's lung disease drug fails mid-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488191653","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488191653?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:05","pubTimestamp":1733227543,"startTime":"0","endTime":"0","summary":"Roivant's lung disease drug fails mid-stage trialDec 3  - Roivant ROIV.O said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of lung disease.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3N3N40TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2488916378","title":"Roivant Sciences Shares Down 2.6% Premarket After Co's Lung Disease Drug Fails to Meet Main Goal in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488916378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488916378?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:05","pubTimestamp":1733227540,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3N3N40TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2488091506","title":"Kinevant Sciences Announces Topline Results From Phase 2 Resolve-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488091506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488091506?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA5LLQYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2488915770","title":"Roivant Announces Topline Results From Phase 2 Resolve-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488915770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488915770?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA535PPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-10","symbol":"ROIV","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-12","symbol":"ROIV","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-08-08","symbol":"ROIV","fiscalQuarterEnding":"2024/06","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-05-30","symbol":"ROIV","fiscalQuarterEnding":"2024/03","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"pre","actualEps":-0.28},{"market":"US","date":"2024-02-13","symbol":"ROIV","fiscalQuarterEnding":"2023/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1707800400000,"reportTimeType":"pre","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.5,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1707969600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2025-04-16","current":-61.552444,"percent":0.046914,"low":-67.975517,"twenty":-6.982171,"median":-3.647828,"eighty":1.795452,"high":2.128992,"avg":-6.490924,"sd":14.626672,"marketCap":7178307547},"quantilePoints":[{"date":"2021-10-01","current":-7.393592,"twenty":-7.393592,"median":-7.393592,"eighty":-7.393592,"marketCap":6566796009},{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-16","current":-61.552444,"twenty":-6.982171,"median":-3.647828,"eighty":1.795452,"marketCap":7178307547}],"updateTime":1744964082066}}}